OBJECTIVE: To determine the efficacy a modified-live Salmonella Dublin vaccine administered PO in an extralabel manner in the prevention of diseases associated with Salmonella Dublin infection. DESIGN: Randomized clinical trial. ANIMALS: 288 preweaned Holstein dairy calves on a commercial dairy farm. PROCEDURES: Calves were orally administered either 2 mL of a commercially available, modified-live Salmonella Dublin vaccine (n = 140) or a placebo (148) at 3 and 10 days of age. Signs of diarrhea and depression were recorded daily. Weight gain between 3 days of age and time of weaning was measured. Fecal samples from clinically depressed or diarrheic calves and fresh tissues samples from calves that died were submitted for bacterial culture of Salmonella organisms. RESULTS: Salmonella organisms were isolated from samples of 1.4% (2/140) and 3.4% (5/148) of calves receiving the vaccine and placebo, respectively. Additionally, 57.1% (80/140) and 60.1 % (89/148) of the vaccinated and control calves, respectively, had at least 1 day with an abnormal fecal score. Calves receiving the vaccine and placebo were not significantly different in terms of overall morbidity rate, Salmonella-specific morbidity rate, or average daily gain. Adverse reactions related to administration of the vaccine were not seen. The attenuated vaccine strain was not isolated from any fecal or tissue samples. CONCLUSIONS AND CLINICAL RELEVANCE: This method of vaccination was safe in young Holstein calves, although it was not effective in reducing the incidence of disease or improving weight gain on this farm. However, the power of this study was limited by a low incidence of clinical salmonellosis.
OBJECTIVE: To determine the efficacy a modified-live Salmonella Dublin vaccine administered PO in an extralabel manner in the prevention of diseases associated with Salmonella Dublin infection. DESIGN: Randomized clinical trial. ANIMALS: 288 preweaned Holstein dairy calves on a commercial dairy farm. PROCEDURES: Calves were orally administered either 2 mL of a commercially available, modified-live Salmonella Dublin vaccine (n = 140) or a placebo (148) at 3 and 10 days of age. Signs of diarrhea and depression were recorded daily. Weight gain between 3 days of age and time of weaning was measured. Fecal samples from clinically depressed or diarrheic calves and fresh tissues samples from calves that died were submitted for bacterial culture of Salmonella organisms. RESULTS:Salmonella organisms were isolated from samples of 1.4% (2/140) and 3.4% (5/148) of calves receiving the vaccine and placebo, respectively. Additionally, 57.1% (80/140) and 60.1 % (89/148) of the vaccinated and control calves, respectively, had at least 1 day with an abnormal fecal score. Calves receiving the vaccine and placebo were not significantly different in terms of overall morbidity rate, Salmonella-specific morbidity rate, or average daily gain. Adverse reactions related to administration of the vaccine were not seen. The attenuated vaccine strain was not isolated from any fecal or tissue samples. CONCLUSIONS AND CLINICAL RELEVANCE: This method of vaccination was safe in young Holstein calves, although it was not effective in reducing the incidence of disease or improving weight gain on this farm. However, the power of this study was limited by a low incidence of clinical salmonellosis.
Authors: Prerna Vohra; Marie Bugarel; Frances Turner; Guy H Loneragan; Jayne C Hope; John Hopkins; Mark P Stevens Journal: Appl Environ Microbiol Date: 2018-01-31 Impact factor: 4.792
Authors: R Reid Harvey; Cindy R Friedman; Stacy M Crim; Michael Judd; Kelly A Barrett; Beth Tolar; Jason P Folster; Patricia M Griffin; Allison C Brown Journal: Emerg Infect Dis Date: 2017-09 Impact factor: 6.883
Authors: Gabriele Ute Maier; Jefferson Breitenbuecher; Jose Pablo Gomez; Festus Samah; Erik Fausak; Megan Van Noord Journal: Vet Anim Sci Date: 2022-02-19